BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27302674)

  • 1. Pharmacokinetic study of meropenem in healthy beagle dogs receiving intermittent hemodialysis.
    Byun SY; Jeong JW; Choi JH; Lee KP; Youn HY; Maeng HJ; Song KH; Koo TS; Seo KW
    J Vet Pharmacol Ther; 2016 Dec; 39(6):560-565. PubMed ID: 27302674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.
    Thalhammer F; Hörl WH
    Clin Pharmacokinet; 2000 Oct; 39(4):271-9. PubMed ID: 11069213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma pharmacokinetics and tissue fluid concentrations of meropenem after intravenous and subcutaneous administration in dogs.
    Bidgood T; Papich MG
    Am J Vet Res; 2002 Dec; 63(12):1622-8. PubMed ID: 12492274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment.
    Rubino CM; Bhavnani SM; Loutit JS; Lohse B; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?
    Varghese JM; Jarrett P; Wallis SC; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA
    J Antimicrob Chemother; 2015 Feb; 70(2):528-33. PubMed ID: 25336163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of plasma and interstitial fluid concentrations of doxycycline and meropenem following constant rate intravenous infusion in dogs.
    Bidgood TL; Papich MG
    Am J Vet Res; 2003 Aug; 64(8):1040-6. PubMed ID: 12926599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of meropenem in subjects with renal insufficiency.
    Leroy A; Fillastre JP; Etienne I; Borsa-Lebás F; Humbert G
    Eur J Clin Pharmacol; 1992; 42(5):535-8. PubMed ID: 1607000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meropenem pharmacokinetics in children and adolescents receiving hemodialysis.
    Goldstein SL; Murry DJ; May S; Aleksic A; Sowinski KM; Blaney S
    Pediatr Nephrol; 2001 Dec; 16(12):1015-8. PubMed ID: 11793091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis.
    Wiesholzer M; Pichler P; Reznicek G; Wimmer M; Kussmann M; Balcke P; Burgmann H; Zeitlinger M; Poeppl W
    Antimicrob Agents Chemother; 2016 May; 60(5):2790-7. PubMed ID: 26902765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery.
    Wittau M; Scheele J; Kurlbaum M; Brockschmidt C; Wolf AM; Hemper E; Henne-Bruns D; Bulitta JB
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6241-7. PubMed ID: 26248353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support.
    Cies JJ; Moore WS; Dickerman MJ; Small C; Carella D; Chopra A; Parker J
    Pharmacotherapy; 2014 Oct; 34(10):e175-9. PubMed ID: 25146254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
    Kielstein JT; Czock D; Schöpke T; Hafer C; Bode-Böger SM; Kuse E; Keller F; Fliser D
    Crit Care Med; 2006 Jan; 34(1):51-6. PubMed ID: 16374156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.
    Robatel C; Decosterd LA; Biollaz J; Eckert P; Schaller MD; Buclin T
    J Clin Pharmacol; 2003 Dec; 43(12):1329-40. PubMed ID: 14615469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and dosing estimation of meropenem in Japanese patients receiving continuous venovenous hemodialysis.
    Kawano S; Matsumoto K; Hara R; Kuroda Y; Ikawa K; Morikawa N; Horino T; Hori S; Kizu J
    J Infect Chemother; 2015 Jun; 21(6):476-8. PubMed ID: 25869915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of meropenem after intravenous, intramuscular and subcutaneous administration to cats.
    Albarellos GA; Montoya L; Passini SM; Lupi MP; Lorenzini PM; Landoni MF
    J Feline Med Surg; 2016 Dec; 18(12):976-980. PubMed ID: 26347549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the pharmacokinetics of meropenem after administration by intravenous injection over 5 min and intravenous infusion over 30 min.
    Kelly HC; Hutchison M; Haworth SJ
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():35-41. PubMed ID: 8543497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.